Search results
Results from the WOW.Com Content Network
Bipartisan bills introduced in Congress Thursday would effectively ban a Chinese genomics firm from doing business in America. Intel officials have warned China is grabbing U.S. genetic info.
The Biotechnology Innovation Organization (BIO), a Washington-based trade association representing biotechnology companies in the U.S. and more than 30 other countries, including WuXi AppTec, had ...
GenScript is a pharmaceutical research and manufacturing service provider with over 200,000 customers in over 100 countries and sales, manufacturing, and research and development presence in China ...
Scrip has now developed into an online global pharma news and analysis service. It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials.
Biotechnology is the research and development in the laboratory using bioinformatics for exploration, extraction, exploitation, and production from any living organisms and any source of biomass by means of biochemical engineering where high value-added products could be planned (reproduced by biosynthesis, for example), forecasted, formulated ...
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. The company was started in 2022.
News. Science & Tech. Shopping. Sports. Weather. US FDA approves Mesoblast's cell therapy for graft-versus-host disease. December 18, 2024 at 4:57 PM
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.